NDC 43742-1760

Cand Combination

Alternaria Tenuis Nees, Aspergillus Niger, Torula Cerevisiae, Candida Albicans, Candida Parapsilosis, Mucor Racemosus, Rhizopus Nigricans, Candida Krusei, Candida Tropicalis

Cand Combination is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Deseret Biologicals, Inc.. The primary component is Alternaria Alternata; Aspergillus Niger Var. Niger; Candida Albicans; Candida Parapsilosis; Candida Tropicalis; Issatchenkia Orientalis Whole; Mucor Racemosus; Rhizopus Stolonifer; Saccharomyces Cerevisiae.

Product ID43742-1760_b39e751d-bd55-4225-9364-f74512340b7e
NDC43742-1760
Product TypeHuman Otc Drug
Proprietary NameCand Combination
Generic NameAlternaria Tenuis Nees, Aspergillus Niger, Torula Cerevisiae, Candida Albicans, Candida Parapsilosis, Mucor Racemosus, Rhizopus Nigricans, Candida Krusei, Candida Tropicalis
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date2020-09-23
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameDeseret Biologicals, Inc.
Substance NameALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; ISSATCHENKIA ORIENTALIS WHOLE; MUCOR RACEMOSUS; RHIZOPUS STOLONIFER; SACCHAROMYCES CEREVISIAE
Active Ingredient Strength12 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL
Pharm ClassesAllergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 43742-1760-1

30 mL in 1 BOTTLE, DROPPER (43742-1760-1)
Marketing Start Date2020-09-23
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Cand Combination" or generic name "Alternaria Tenuis Nees, Aspergillus Niger, Torula Cerevisiae, Candida Albicans, Candida Parapsilosis, Mucor Racemosus, Rhizopus Nigricans, Candida Krusei, Candida Tropicalis"

NDCBrand NameGeneric Name
43742-1760Cand CombinationAlternaria Tenuis Nees, Aspergillus Niger, Torula Cerevisiae, Candida Albicans, Candida Parapsilosis, Mucor Racemosus, Rhizopus Nigricans, Candida Krusei, Candida Tropicalis
43742-1565Candida SppAlternaria Tenuis Nees, Aspergillus Niger, Torula Cerevisiae, Candida Albicans, Candida Parapsilosis, Mucor Racemosus, Rhizopus Nigricans, Candida Krusei, Candida Tropicalis

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.